SEC Form 4 · accession 0001179110-18-013625
HALOZYME THERAPEUTICS, INC. · HALO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Connie Matsui
Director
Period of report
Dec 7, 2018
Accepted (ET)
Dec 10, 2018 · 4:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001159036
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 7, 2018 | G | 15,000 | $0.00 | D | 227,751 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a bona fide gift to a charitable organization.